BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21818366)

  • 1. ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function.
    Xia H; Suda S; Bindom S; Feng Y; Gurley SB; Seth D; Navar LG; Lazartigues E
    PLoS One; 2011; 6(7):e22682. PubMed ID: 21818366
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chen XY; Lin C; Liu GY; Pei C; Xu GQ; Gao L; Wang SZ; Pan YX
    J Appl Physiol (1985); 2022 Jun; 132(6):1460-1467. PubMed ID: 35546127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.
    Feng Y; Xia H; Cai Y; Halabi CM; Becker LK; Santos RA; Speth RC; Sigmund CD; Lazartigues E
    Circ Res; 2010 Feb; 106(2):373-82. PubMed ID: 19926873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension.
    Kang Y; Ding L; Dai H; Wang F; Zhou H; Gao Q; Xiong X; Zhang F; Song T; Yuan Y; Zhu G; Zhou Y
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31466304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
    Xia H; Sriramula S; Chhabra KH; Lazartigues E
    Circ Res; 2013 Oct; 113(9):1087-1096. PubMed ID: 24014829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
    Bodiga S; Zhong JC; Wang W; Basu R; Lo J; Liu GC; Guo D; Holland SM; Scholey JW; Penninger JM; Kassiri Z; Oudit GY
    Cardiovasc Res; 2011 Jul; 91(1):151-61. PubMed ID: 21285291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension.
    Li HB; Qin DN; Ma L; Miao YW; Zhang DM; Lu Y; Song XA; Zhu GQ; Kang YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):141-9. PubMed ID: 24937322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.
    Xia H; de Queiroz TM; Sriramula S; Feng Y; Johnson T; Mungrue IN; Lazartigues E
    Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R370-8. PubMed ID: 25519733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.
    Sriramula S; Cardinale JP; Lazartigues E; Francis J
    Cardiovasc Res; 2011 Dec; 92(3):401-8. PubMed ID: 21952934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
    Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice.
    Xia H; Feng Y; Obr TD; Hickman PJ; Lazartigues E
    Hypertension; 2009 Feb; 53(2):210-6. PubMed ID: 19124678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
    Feng Y; Hans C; McIlwain E; Varner KJ; Lazartigues E
    PLoS One; 2012; 7(11):e48910. PubMed ID: 23155428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension.
    Su Q; Qin DN; Wang FX; Ren J; Li HB; Zhang M; Yang Q; Miao YW; Yu XJ; Qi J; Zhu Z; Zhu GQ; Kang YM
    Toxicol Appl Pharmacol; 2014 Apr; 276(2):115-20. PubMed ID: 24576725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane trafficking of NADPH oxidase p47(phox) in paraventricular hypothalamic neurons parallels local free radical production in angiotensin II slow-pressor hypertension.
    Coleman CG; Wang G; Faraco G; Marques Lopes J; Waters EM; Milner TA; Iadecola C; Pickel VM
    J Neurosci; 2013 Mar; 33(10):4308-16. PubMed ID: 23467347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation.
    Feng Y; Yue X; Xia H; Bindom SM; Hickman PJ; Filipeanu CM; Wu G; Lazartigues E
    Circ Res; 2008 Mar; 102(6):729-36. PubMed ID: 18258853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.
    Zheng H; Liu X; Patel KP
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2402-12. PubMed ID: 21963832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
    Chhabra KH; Xia H; Pedersen KB; Speth RC; Lazartigues E
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E874-84. PubMed ID: 23462816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons.
    Mukerjee S; Gao H; Xu J; Sato R; Zsombok A; Lazartigues E
    Hypertension; 2019 Nov; 74(5):1181-1191. PubMed ID: 31564162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.
    Patel VB; Bodiga S; Basu R; Das SK; Wang W; Wang Z; Lo J; Grant MB; Zhong J; Kassiri Z; Oudit GY
    Circ Res; 2012 May; 110(10):1322-35. PubMed ID: 22474255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.